ALYSE MURKERSON: Open Payments
NPI 1568020949 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 28 payments from 11 companies in 2025. Trend: 2023 $409 · 2024 $434 · 2025 $531
Food & beverage: $531
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $236 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Medtronic, Inc. | 1 | $45 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $32 |
| Smith+Nephew, Inc. | 1 | $22 |
| PFIZER INC. | 1 | $19 |
| Aurinia Pharma U.S., Inc. | 1 | $19 |
| Amgen Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
Products named: MOUNJARO, JARDIANCE, SYMPLICITY G3, Kerendia, BREZTRI, COLLAGENASE SANTYL, LUPKYNIS, TRELEGY ELLIPTA.
Industry payments across AL — which companies pay providers there.
